Date: 26-June-2019
The list of Top 100 Pharma Companies in China – 2018 was issued by MENET, including Xiangxue on it. The main selection factors are R&D investment and end-market demands that relates to the choices of clinicians and patients.
由米內(nèi)網(wǎng)發(fā)布了“2018年度中國(guó)醫(yī)藥工業(yè)百?gòu)?qiáng)系列榜單”, 香雪制藥上榜。本次評(píng)選聚焦醫(yī)藥工業(yè)企業(yè)創(chuàng)新驅(qū)動(dòng)力和專業(yè)推廣力,創(chuàng)新驅(qū)動(dòng)力主要從企業(yè)研發(fā)投入R&D綜合指標(biāo)進(jìn)行評(píng)判,專業(yè)推廣力則重點(diǎn)根據(jù)臨床醫(yī)生和患者的最終選擇需求所決定的終端定量定義。